Diabetes And Oncology Drive Interest in China - Shanghai R&D Summit
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Pharma companies and investors are focusing their interest in China, as they are elsewhere, on diabetes and oncology, but they face unique challenges, according to panelists at a recent R&D conference in Shanghai